MANIFOLD
[ACX 2026] Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
19
Ṁ5.1kṀ5.3k
Dec 31
19%
chance


Resolves according to Metaculus resolution.

Metaculus high-level description:
This question will resolve as Yes if any of the US FDA, UK MHRA, or the EU Commission authorizes the use or sale of a therapy whose primary mechanism directly editing the patient's genomic DNA for any human condition other than sickle cell disease and beta thalassemia before January 1, 2027.

Market context
Get
Ṁ1,000
to start trading!
Sort by:
bought Ṁ20 YES

I go with my heart- Trump/RFK will cause a "pole vault" effect that will separate other nations from USA "leadership" in medical advances. If Trump doesn't kill us all, this will be a historic time for science and technology. Thanks for market!

© Manifold Markets, Inc.TermsPrivacy